Zenlabs Ethica Limited Share Price
Zenlabs Ethica Limited Returns Calculator
About Zenlabs Ethica Limited
Zenlabs Ethica Limited is an India-based pharmaceutical contract manufacturing company. The Company develops, markets and exports a range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-bacterial Drugs, Nutraceuticals, and others. The Company operates in the pharmaceutical’s formulations segment, which primarily includes marketing and distribution of pharmaceutical products. Its divisions include Zenlabs, Coles Pharma and Mega Star. Its product categories include analgesics & anti-inflammatory, skin preparations, neurological disorders, eye, ear and nasal drops, anti-diabetic, anti-depressant, anti-infective, anti-emetic, steroid and anabolic steroids, antihypertensive drugs, anti-allergic, anti-cold and cough syrup, nutraceuticals, antacid, enzymes and appetite stimulant, ayurvedic preparation, git disorders, soap, and other pharmaceutical drugs. Its brands include RBC Red Super Active and Zenovit.
Zenlabs Ethica Limited Financial Highlights
- Revenue: Zenlabs Ethica Limited reported revenue of ₹47.10 crore in FY26 vs ₹51.47 crore in FY25. It showed a decrease of 8.49% on a yearly basis.
- Operating Profit: Zenlabs Ethica Limited reported an operating loss of ₹1.81 crore in FY26 vs ₹0.43 crore in FY25. It showed a decrease of 520.93% on a year-on-year basis.
- Net Profit: Zenlabs Ethica Limited reported a net loss of ₹1.94 crore in FY26 vs ₹0.27 crore in FY25. It showed a decrease of 818.52% on a yearly basis.
Zenlabs Ethica Limited Quarterly Result Highlights
- Zenlabs Ethica Limited reported revenue of ₹10.70 crore in Mar 2026, compared with ₹12.43 crore in Dec 2025, representing a decrease of 13.92% on a quarter-on-quarter (QoQ) basis.
- Zenlabs Ethica Limited reported an operating profit of ₹0.08 crore in Mar 2026, compared with ₹2.01 crore in Dec 2025, representing an increase of 103.98% on a quarter-on-quarter (QoQ) basis.
- Zenlabs Ethica Limited reported a profit of ₹0.00 crore in Mar 2026, compared with ₹2.01 crore in Dec 2025, reflecting an increase of 100.00% on a QoQ basis.
- The earnings per share (EPS) of Zenlabs Ethica Limited stood at ₹0.41 during Mar 2026.
| Sep 2025 | 0.00% |
|---|---|
| Dec 2025 | 0.00% |
| Mar 2026 | 0.00% |
| Jun 2026 | 0.00% |
Zenlabs Ethica Limited Shareholder Returns
Zenlabs Ethica Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,66,155.00 | 38.47 | 5.58 | 13.74% | 0.61 | 17.33% | 93.24 | 0.82% | 0.48 | 10.90 |
| Divis Laboratories | 2,25,648.00 | 77.15 | 13.46 | 15.32% | 0.00 | 19.56% | 629.49 | 0.35% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,86,000.00 | 86.03 | 22.06 | 25.49% | 1.69 | 13.85% | 222.76 | 0.69% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,17,007.00 | 25.48 | 4.32 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,18,027.00 | 35.17 | 3.43 | 11.27% | 0.00 | 14.95% | 423.36 | 0.89% | 0.45 | 43.52 |
| Lupin | 1,03,380.00 | 18.62 | 4.61 | 23.76% | 0.04 | 24.88% | 659.05 | 0.80% | 0.57 | 129.18 |
| Mankind Pharma | 99,862.40 | 48.30 | 6.13 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Dr. Reddy's Laboratories | 1,00,662.00 | 31.62 | 2.64 | 11.07% | 0.18 | 12.54% | 377.96 | 0.66% | 0.41 | 38.68 |
| Laurus Labs | 99,474.20 | 91.23 | 18.77 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Aurobindo Pharma | 96,215.60 | 25.93 | 2.54 | 9.25% | 0.19 | 11.76% | 391.14 | 0.24% | 0.38 | 41.58 |
Zenlabs Ethica Limited Financials
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹51.42 | ₹58.56 | ₹66.89 | ₹69.09 |
| Other Income | ₹0.05 | ₹0.30 | ₹0.13 | ₹0.09 |
| Total Revenue | ₹51.47 | ₹58.86 | ₹67.01 | ₹69.18 |
| Total Expenses | ₹51.04 | ₹58.28 | ₹65.77 | ₹67.95 |
| Profit Before Tax | ₹0.43 | ₹0.58 | ₹0.67 | ₹1.22 |
| Tax | ₹0.16 | ₹0.16 | ₹0.19 | ₹0.44 |
| Profit After Tax | ₹0.27 | ₹0.42 | ₹0.49 | ₹0.78 |
| EPS - Basic | ₹0.41 | ₹0.65 | ₹0.75 | ₹1.20 |
| EPS - Diluted | ₹0.41 | ₹0.65 | ₹0.75 | ₹1.20 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹0.43 | ₹0.58 | ₹0.67 | ₹1.22 |
| Income before WC changes | ₹2.70 | ₹2.69 | ₹2.95 | ₹2.40 |
| Change in Assets | -₹1.00 | ₹1.13 | -₹4.56 | -₹6.02 |
| Change in Liabilities | ₹2.34 | -₹12.75 | ₹3.40 | ₹3.36 |
| Change in WC | ₹1.34 | -₹11.62 | -₹1.17 | -₹2.66 |
| Cash flow from Operations | ₹3.83 | -₹9.06 | ₹1.52 | -₹0.38 |
| Cash flow from Investing | ₹0.14 | ₹0.11 | -₹1.47 | ₹0.00 |
| Cash flow from Financing | -₹3.08 | ₹8.24 | ₹0.06 | ₹0.31 |
| Total Cash Flow | ₹0.88 | -₹0.71 | ₹0.11 | -₹0.07 |
| Cash (Start of the year) | ₹0.91 | ₹1.62 | ₹1.51 | ₹1.57 |
| Cash (End of the year) | ₹1.79 | ₹0.91 | ₹1.62 | ₹1.51 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹3.27 | ₹4.71 | ₹5.99 | ₹4.50 |
| Current Assets | ₹37.35 | ₹35.55 | ₹37.50 | ₹33.40 |
| Total Assets | ₹40.62 | ₹40.26 | ₹43.49 | ₹37.90 |
| Current Liabilities | ₹28.12 | ₹27.02 | ₹29.45 | ₹25.20 |
| Net Current Asset | ₹9.23 | ₹8.52 | ₹8.05 | ₹8.20 |
| Non-Current Liabilities | ₹2.07 | ₹3.11 | ₹4.34 | ₹3.36 |
| Equity Capital | ₹10.43 | ₹10.12 | ₹9.70 | ₹9.33 |
| Total Equity & Liabilities | ₹40.62 | ₹40.26 | ₹43.49 | ₹37.90 |
| 13 Aug | 0L |
|---|---|
| 12 Aug | 0L |
| 11 Aug | 0L |
| 10 Aug | 0L |
| 7 Aug | 0L |
| Average | 0L |
Popular Stocks
Zenlabs Ethica Limited Share Price FAQs
What is Zenlabs Ethica Limited share price today?
Zenlabs Ethica Limited share price is ₹26.26 as on 13 Aug, 2026, 15:26 IST.
How has the Zenlabs Ethica Limited share price performed in the past?
In the last 1 year, Zenlabs Ethica Limited delivered a return of -16.30%. The Zenlabs Ethica Limited share price hit a high of ₹39.99 and low of ₹16.50.
How much is the Mutual Fund shareholding in Zenlabs Ethica Limited shares?
The Mutual Fund Shareholding in Zenlabs Ethica Limited was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of Zenlabs Ethica Limited shares ?
The 52-week high and low of Zenlabs Ethica Limited share is ₹39.99 and ₹16.50 as of 13 Aug, 2026.
What is the market cap of Zenlabs Ethica Limited?
The market capitalisation of Zenlabs Ethica Limited is ₹17.08 Crores as on 13 Aug, 2026.
What are the stock symbols of Zenlabs Ethica Limited?
The stock symbol of Zenlabs Ethica Limited is 530697 on the BSE, and the ISIN is INE546F01013.
What was yesterday's closing price for Zenlabs Ethica Limited shares ?
Zenlabs Ethica Limited shares closed yesterday at ₹26.24 on BSE
How to buy Zenlabs Ethica Limited shares?
To buy Zenlabs Ethica Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Zenlabs Ethica Limited shares on Holidays?
No, shares of Zenlabs Ethica Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Zenlabs Ethica Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Zenlabs Ethica Limited?
The PE and PB ratio of Zenlabs Ethica Limited is -8.84 and 2.01 respectively, as on 13 Aug, 2026, 15:26 IST.